Ameriprise
VERA icon

Ameriprise’s Vera Therapeutics VERA Stock Holding History

Ameriprise’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.48M Buy
57,895
+42,922
+287% +$1.6M ﹤0.01% 2963
2026
Q1 		$602K Sell
14,973
-168
-1% -$7.24K ﹤0.01% 3514
2025
Q4 		$767K Buy
15,141
+55
+0.4% +$1.95K ﹤0.01% 3455
2025
Q3 		$438K Sell
15,086
-2,302
-13% -$53.2K ﹤0.01% 3671
2025
Q2 		$410K Sell
17,388
-6,361
-27% -$143K ﹤0.01% 3593
2025
Q1 		$570K Sell
23,749
-6,272
-21% -$202K ﹤0.01% 3435
2024
Q4 		$1.27M Buy
30,021
+7,227
+32% +$320K ﹤0.01% 3131
2024
Q3 		$1.01M Sell
22,794
-792
-3% -$30.1K ﹤0.01% 3219
2024
Q2 		$853K Buy
23,586
+12,602
+115% +$500K ﹤0.01% 3216
2024
Q1 		$474K Buy
+10,984
New +$391K ﹤0.01% 3437

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ameriprise's VERA Position: Q2 2026 in Review

Ameriprise increased its Vera Therapeutics (VERA) stake by 287% in Q2 2026, buying an estimated $1.6M and bringing the position to 57,895 shares worth $2.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2963.

Ameriprise first reported a position in VERA in Q1 2024 and has held it in 10 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Ameriprise held 57,895 shares of Vera Therapeutics worth $2.48M as of Q2 2026.
  • Ameriprise bought 42,922 Vera Therapeutics shares in Q2 2026, an estimated $1.6M.
  • Vera Therapeutics made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2963 holding.
  • Ameriprise first reported a position in Vera Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.